Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?
Read More 4 minute read Pharma Industry News Exicure completes Phase 2 trial of GPC-100 for stem cell mobilization in multiple myeloma patients Exicure (NASDAQ: XCUR) completes final patient visit in Phase 2 GPC-100 trial for stem cell mobilization in multiple myeloma; topline results expected Q4 2025. bySoujanya RaviAugust 3, 2025